questionsmedicales.fr
Aliments et boissons
Aliments
Produits laitiers
Lait
Lait : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lait : Questions médicales les plus fréquentes",
"headline": "Lait : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lait : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-01",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lait"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits laitiers",
"url": "https://questionsmedicales.fr/mesh/D003611",
"about": {
"@type": "MedicalCondition",
"name": "Produits laitiers",
"code": {
"@type": "MedicalCode",
"code": "D003611",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Babeurre",
"alternateName": "Buttermilk",
"url": "https://questionsmedicales.fr/mesh/D000070696",
"about": {
"@type": "MedicalCondition",
"name": "Babeurre",
"code": {
"@type": "MedicalCode",
"code": "D000070696",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350.525.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kéfir",
"alternateName": "Kefir",
"url": "https://questionsmedicales.fr/mesh/D000070716",
"about": {
"@type": "MedicalCondition",
"name": "Kéfir",
"code": {
"@type": "MedicalCode",
"code": "D000070716",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350.525.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Koumiss",
"alternateName": "Koumiss",
"url": "https://questionsmedicales.fr/mesh/D000070736",
"about": {
"@type": "MedicalCondition",
"name": "Koumiss",
"code": {
"@type": "MedicalCode",
"code": "D000070736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350.525.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lait humain",
"alternateName": "Milk, Human",
"url": "https://questionsmedicales.fr/mesh/D008895",
"about": {
"@type": "MedicalCondition",
"name": "Lait humain",
"code": {
"@type": "MedicalCode",
"code": "D008895",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350.525.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lactosérum",
"alternateName": "Whey",
"url": "https://questionsmedicales.fr/mesh/D000067796",
"about": {
"@type": "MedicalCondition",
"name": "Lactosérum",
"code": {
"@type": "MedicalCode",
"code": "D000067796",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J02.500.350.525.760"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lait",
"alternateName": "Milk",
"code": {
"@type": "MedicalCode",
"code": "D008892",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alen Dzidic",
"url": "https://questionsmedicales.fr/author/Alen%20Dzidic",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal Science, University of Zagreb, Zagreb, Croatia."
}
},
{
"@type": "Person",
"name": "Xin Wang",
"url": "https://questionsmedicales.fr/author/Xin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Riddet Institute, Massey University, Private Bag 11 222, Palmerston North 4442, New Zealand. H.Singh@massey.ac.nz."
}
},
{
"@type": "Person",
"name": "Ylva Persson",
"url": "https://questionsmedicales.fr/author/Ylva%20Persson",
"affiliation": {
"@type": "Organization",
"name": "Udder Health Bangladesh, Chattogram, 4225, Bangladesh."
}
},
{
"@type": "Person",
"name": "T J DeVries",
"url": "https://questionsmedicales.fr/author/T%20J%20DeVries",
"affiliation": {
"@type": "Organization",
"name": "Dept. of Animal Biosciences, University of Guelph, ON, N1G 2W1, Canada; Mastitis Network, Saint-Hyacinthe, QC, J2S 2M2, Canada. Electronic address: tdevries@uoguelph.ca."
}
},
{
"@type": "Person",
"name": "P Silva Boloña",
"url": "https://questionsmedicales.fr/author/P%20Silva%20Bolo%C3%B1a",
"affiliation": {
"@type": "Organization",
"name": "Department of Dairy Science, University of Wisconsin, Madison 53706. Electronic address: psilva2@wisc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36600424",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-067251"
}
},
{
"@type": "ScholarlyArticle",
"name": "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35617986",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S2213-2600(22)00088-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.",
"datePublished": "2024-08-14",
"url": "https://questionsmedicales.fr/article/39161682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/DDDT.S472651"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study.",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36612875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20010552"
}
},
{
"@type": "ScholarlyArticle",
"name": "Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35725922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41591-022-01861-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Aliments et boissons",
"item": "https://questionsmedicales.fr/mesh/D019602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Aliments",
"item": "https://questionsmedicales.fr/mesh/D005502"
},
{
"@type": "ListItem",
"position": 4,
"name": "Produits laitiers",
"item": "https://questionsmedicales.fr/mesh/D003611"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lait",
"item": "https://questionsmedicales.fr/mesh/D008892"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lait - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lait",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lait",
"description": "Comment diagnostiquer une intolérance au lactose ?\nQuels tests pour une allergie au lait ?\nComment identifier une infection liée au lait ?\nQuels signes indiquent une contamination du lait ?\nComment diagnostiquer une carence en calcium ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lait",
"description": "Quels symptômes d'une intolérance au lactose ?\nQuels signes d'une allergie au lait ?\nComment reconnaître une infection alimentaire ?\nQuels symptômes d'une carence en calcium ?\nQuels signes d'une surconsommation de lait ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lait",
"description": "Comment prévenir l'intolérance au lactose ?\nQuelles mesures pour éviter une allergie au lait ?\nComment prévenir les infections alimentaires ?\nQuelles stratégies pour éviter une carence en calcium ?\nComment prévenir les symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lait",
"description": "Quel traitement pour l'intolérance au lactose ?\nComment traiter une allergie au lait ?\nQuel traitement pour une infection alimentaire ?\nComment traiter une carence en calcium ?\nQuel traitement pour les symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lait",
"description": "Quelles complications d'une intolérance au lactose ?\nQuelles complications d'une allergie au lait ?\nQuelles complications d'une infection alimentaire ?\nQuelles complications d'une carence en calcium ?\nQuelles complications d'une surconsommation de lait ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lait",
"description": "Quels facteurs de risque pour l'intolérance au lactose ?\nQuels facteurs de risque pour une allergie au lait ?\nQuels facteurs de risque pour les infections alimentaires ?\nQuels facteurs de risque pour une carence en calcium ?\nQuels facteurs de risque pour des troubles digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D008892?mesh_terms=Double-Blind+Method&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intolérance au lactose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de tolérance au lactose ou un test respiratoire à l'hydrogène peut être effectué."
}
},
{
"@type": "Question",
"name": "Quels tests pour une allergie au lait ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cutanés ou des analyses sanguines pour détecter des anticorps IgE spécifiques au lait."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection liée au lait ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cultures bactériennes peuvent être réalisées sur des échantillons de lait suspect."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une contamination du lait ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de couleur, d'odeur ou de texture peuvent indiquer une contamination."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en calcium ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage sanguin du calcium et des tests de densité osseuse peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intolérance au lactose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ballonnements, douleurs abdominales, diarrhée après consommation de lait."
}
},
{
"@type": "Question",
"name": "Quels signes d'une allergie au lait ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons, gonflements, et parfois anaphylaxie."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection alimentaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes comme nausées, vomissements, diarrhée, et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une carence en calcium ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Crampes musculaires, engourdissements, et fragilité osseuse."
}
},
{
"@type": "Question",
"name": "Quels signes d'une surconsommation de lait ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ballonnements, diarrhée, et douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'intolérance au lactose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Introduire progressivement les produits laitiers et choisir des alternatives sans lactose."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter une allergie au lait ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition précoce aux protéines de lait chez les nourrissons à risque."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections alimentaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les règles d'hygiène lors de la manipulation et de la conservation des aliments."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour éviter une carence en calcium ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des aliments riches en calcium et envisager des suppléments si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les symptômes digestifs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée et éviter les aliments irritants."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'intolérance au lactose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les produits laitiers ou utiliser des enzymes lactases pour faciliter la digestion."
}
},
{
"@type": "Question",
"name": "Comment traiter une allergie au lait ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les produits laitiers et utiliser des antihistaminiques en cas de réaction."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une infection alimentaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Hydratation et, si nécessaire, antibiotiques selon le type d'infection."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en calcium ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suppléments de calcium et vitamine D, et augmentation de l'apport alimentaire."
}
},
{
"@type": "Question",
"name": "Quel traitement pour les symptômes digestifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Probiotiques et modifications alimentaires peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une intolérance au lactose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des troubles digestifs chroniques et une malabsorption des nutriments."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une allergie au lait ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut provoquer des réactions anaphylactiques graves et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une infection alimentaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner une déshydratation sévère et des complications systémiques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une carence en calcium ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut mener à l'ostéoporose et à des fractures osseuses fréquentes."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une surconsommation de lait ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer des troubles digestifs et un déséquilibre nutritionnel."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'intolérance au lactose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, origine ethnique, et antécédents familiaux d'intolérance."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour une allergie au lait ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antécédents familiaux d'allergies, exposition précoce aux protéines de lait."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les infections alimentaires ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Manipulation inadéquate des aliments, consommation de produits laitiers non pasteurisés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour une carence en calcium ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Régime alimentaire pauvre en produits laitiers, maladies digestives chroniques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour des troubles digestifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Alimentation déséquilibrée, stress, et antécédents de troubles gastro-intestinaux."
}
}
]
}
]
}
Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the on...
ImmunoSep is a randomised placebo-controlled phase 2 clinical trial with a double-dummy design in which the effect of precision immunotherapy on sepsis phenotypes with MALS and immunoparalysis is stud...
The protocol is approved by the German Federal Institute for Drugs and Medical Devices; the National Ethics Committee of Greece and by the National Organization for Medicines of Greece; the Central Co...
NCT04990232....
Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone p...
In this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), a...
Between Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (...
In hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in simi...
National Institute of Allergy and Infectious Diseases....
This study aimed to establish the 95% effective dose (ED95) of esketamine in combination with propofol for hysteroscopy and then to evaluate its efficacy and safety profile....
This prospective, double-blind, randomized controlled trial consisted of two cohorts. In cohort 1, 45 women aged 18-65 years undergoing hysteroscopy were randomly assigned to either group E (esketamin...
The ED95 of esketamine was 0.254 mg/kg (95% CI: 0.214-1.004), while that of alfentanil was 9.121 μg/kg (95% CI: 8.479-13.364). The anesthesia success rate was 93.0% in group E and 95.2% in group A (p ...
This study determined the ED 95 dose of esketamine for intravenous general anesthesia during hysteroscopy. Esketamine showed less respiratory and hemodynamic depression, as well as fewer adverse effec...
www.chictr.org.cn, (ChiCTR2300077283); registered November 3, 2023....
Electroencephalography (EEG) is pivotal in the clinical assessment of epilepsy, and sleep is known to improve the diagnostic yield of its recording. Sleep-EEG recording is generally reached by either ...
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease that may advance to fibrosis and lead to mortality; however, no pharmacotherapy is currently available. We tested the hypothesis t...
Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across...
To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement....
The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The p...
UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain...
High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wile...
To determine whether intravenous vitamin C compared with placebo, reduces vasopressor requirements in patients with vasoplegic shock....
Double-blinded, randomised clinical trial (RCT) conducted in two intensive care units in Perth, Australia. Vasopressor requirements at enrolment needed to be >10 μg/min noradrenaline after hypovolaemi...
Of the 71 patients randomised (35 vitamin C, 36 placebo group), the median vasopressor duration was 44 h [95% CI, 37-54 h] and 55 h [95% CI, 33-66 h]) in the vitamin C and placebo groups (p = 0.057). ...
In this RCT of patients with vasoplegic shock of at least moderate severity, the use of IV vitamin C compared with placebo did not significantly reduce the duration of vasopressors....
Prospective registration - trial number ACTRN12617001392358....
Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality. We sought to evaluate the safety and effect of pirfenidone on disease progression in such...
We conducted a single-centre, randomised, double-blinded, placebo-controlled trial in adults with FHP and disease progression. Patients were assigned in a 2:1 ratio to receive either oral pirfenidone ...
After randomising 40 patients, enrolment was interrupted by the COVID-19 pandemic. There was no significant between-group difference in FVC% at week 52 (mean difference -0.76%, 95% CI -6.34 to 4.82). ...
The trial was underpowered to detect a difference in the primary end point. Pirfenidone was found to be safe and improved PFS in patients with FHP....
NCT02958917....
Pain after soft tissue injuries in and around the ankle is a troublesome process in terms of patient comfort and mobilization. The aim of this study was to compare the analgesic efficacy of intravenou...
We conducted a prospective, double-blind, randomized controlled study in a tertiary hospital. The patients were divided into two groups as those administered IV 400 mg ibuprofen and IV 20 mg tenoxicam...
One hundred and twenty-four patients were included in the study. There were 62 patients in the tenoxicam group and 62 patients in the ibuprofen group. When VAS scores were compared, it was found that ...
We hypothesize that synbiotic supplementation could modulate the intestinal microbiota and subsequently, improve the condition of hypothyroid patients....
Fifty-six adult hypothyroid patients were recruited to this double-blind, placebo-controlled, randomized clinical trial. The intervention was 10 weeks of synbiotic (500 mg of 109 CFU/g probiotics plus...
Analysis on 51 patients who completed the trial showed that TSH and depression (p> 0.05) did not change significantly, while serum FT4 significantly increased in both groups (p = 0.03 and p = 0.02 in ...
Ten-week supplementation with synbiotic had no favorable effect on depression and TSH, but it improved blood pressure and quality of life in patients with hypothyroidism. More trials are needed to sup...
IRCT20210926052583N1, Iranian Registry of Clinical Trials (IRCT), registered October 1st, 2021....